Advanced Materials & Manufacturing
Innospec
30-Second Executive Brief
Executive Assessment
Innospec functions as a regional institution within Advanced Materials & Manufacturing, backed by 0% sourcing coverage, with accelerating strategic relevance.
- Maintains 3 mapped relationships across the graph
- 0% sourcing coverage across sourced relationships
- Tracked as regional institution within the Advanced Materials & Manufacturing category
Executive Snapshot
- Strategic Role
- Regional Institution
- Sourcing Coverage
- 0%
- Ecosystem Influence
- Moderate
- Strategic Momentum
- Accelerating
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 3
- Technology Domains
- 2
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
Innospec manufactures and supplies fuel additives that improve fuel efficiency, boost engine performance, and reduce harmful emissions, alongside personal care and performance chemicals. Trailing twelve-month revenue was $1.8 billion, with Q2 2026 revenue of $491.4 million, up 12% year-over-year.
Leading Indicators
Hiring and patent filing trends — the underlying numbers Momentum is computed from. Insider filing activity is tracked separately under Sources below.
Additional Intelligence Signals
Patent citation lineage, earnings-call mentions, and federal contract disclosures — automatically collected, not yet visible anywhere else on the site.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
2 sources
- GlobeNewswire — Innospec Reports Second Quarter 2026 Financial Resultscompany
- StockTitan — Innospec Q2 Earnings: Revenue Up 12% to $491Mnews
Latest Activity
Insider Filing Activity
Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Sep 7, 2026
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding Innospec — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Market Intelligence
UnverifiedCredibly-reported claims — analyst notes, sourcing citing “people familiar with the matter,” deals where the companies involved declined to comment — that haven't been officially confirmed. Kept structurally separate from the sourced evidence above; treat as a lead worth researching further, not an established fact.
Debt-free balance sheet with broad-based growth positions Innospec unusually well for opportunistic M&A versus leveraged specialty-chemicals peers
38% confidenceInnospec's combination of double-digit growth across all three business segments and a debt-free balance sheet with over $250 million in cash stands out against several specialty-chemicals peers in this batch (e.g., Huntsman pursuing a merger partly to manage cost pressure, FMC targeting ~$1B of debt reduction), suggesting Innospec is comparatively well positioned to pursue opportunistic M&A from a position of strength rather than necessity.
This comparative positioning is InsightNodes' own synthesis across multiple companies' disclosed balance-sheet and strategic conditions; Innospec's own release does not compare its financial position to specific named peers.
InsightNodes analysis of Innospec Q2 2026 results · Aug 13, 2026
Innospec's Timeline
A sourced, dated history of Innospec's key moments — founding to present.
Aug 2026 · Q2 2026 revenue up 12% to $491M; debt-free with broad-based segment growth
Innospec reported Q2 2026 adjusted EPS of $1.27 on revenue of $491.4 million (up 12% YoY), beating estimates by 21%, with Performance Chemicals up 9% to $190.3 million, Fuel Specialties up 12% to $185.7 million, and Oilfield Services up 14% to $115.4 million (operating income up 40% on DRA plant expansion and Middle East demand). The company holds over $250 million in cash with no debt.